Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 1

Tiroid disfonksiyonlu hastalarda kalp hastalığı: Hipertiroidi, hipotiroidi ve ötesi

Heart disease in patients with thyroid dysfunction: Hyperthyroidism, hypothyroidism and beyond

Pages
62–66
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The present manuscript provides an overview of thyroid physiology and patho- physiology, with a particular focus on cardiovascular disease in patients with milder forms of thyroid dysfunction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The thyroid and the cardiovascular system are closely related, both in physiological and pathological conditions.
📊
Key Findings & Data:The adverse consequenc- es on the heart of overt thyroid disease are well-known and even subclinical forms of both hyperthyroidism and hypothyroidism are associ- ated with increased cardiovascular mortality.
💡
Conclusion & Impact:The present manuscript provides an overview of thyroid physiology and patho- physiology, with a particular focus on cardiovascular disease in patients with milder forms of thyroid dysfunction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The thyroid and the cardiovascular system are closely related, both in physiological and pathological conditions. The adverse consequenc- es on the heart of overt thyroid disease are well-known and even subclinical forms of both hyperthyroidism and hypothyroidism are associ- ated with increased cardiovascular mortality. In recent years, attention has shifted towards milder forms of thyroid disease, such as the so-called “low T3 syndrome”, which is characterized by an isolated reduction in circulating levels of the biologically active form of thyroid hormone, triiodothyronine (T3). Furthermore, variations of T3 within the physiological range have been linked to coronary artery disease, one of the leading causes of morbidity and mortality worldwide. The present manuscript provides an overview of thyroid physiology and patho- physiology, with a particular focus on cardiovascular disease in patients with milder forms of thyroid dysfunction.

Özet

Tiroit ve kardiyovasküler sistem hem fizyolojik hem patolojik durumlarla yakından ilişkilidir. Aşikar tiroid hastalığının kalp üzerindeki olumsuz sonuçları iyi bilinmektedir ve hatta hem hipertiroidinin hem de hipotiroidinin subklinik formları bile kardiyovasküler mortalite artışı ile ilişkilidir. Son yıllarda, dikkatler triiodothyronine (T3), tiroid hormonunun biyolojik aktif formunun dolaşımdaki düzeylerinde izole olan reduk- siyonu ile karakterize “düşük T3 sendromu” gibi söylenen tiroid hastalığının daha hafif formlarına doğru kaymıştır. Ayrıca, fizyolojik sınırlardaki T3’ün varyasyonları dünyada, morbidite ve mortalite nedenlerinin başında gelenlerinden koroner arter hastalığı ile bağlantılı bulunmuştur. Sunulan yazı tiroid disfonksiyonunun daha hafif formlu hastalarda kardiyovasküler hastalık üzerinde özellikle odaklanarak, tiroid fizyolojisi ve patofizyolojisini gözden geçirmeyi sağlamaktadır.

🔖

Cite This Article

COCEANI, M. (2022). Tiroid disfonksiyonlu hastalarda kalp hastalığı: Hipertiroidi, hipotiroidi ve ötesi. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 1, 62–66. https://ajindex.com/articles/436299

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116: 1725-35. [CrossRef] 2. Forfar JC, Muir AL, Sawers SA, Toft AD. Abnormal left ventricular function in hyperthyroidism: evidence for possible reversible car- diomyopathy. N Engl J Med 1982; 307: 1165-70. [CrossRef] 3. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular sys- tem. N Engl J Med 2001; 344: 501-9. [CrossRef] 4. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003; 88: 2438-44. [CrossRef] 5. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The ben- eficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007; 92: 1715-23. [CrossRef] 6. Danese MD, Ladenson PW, Meinert CL, Powe NR.Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000; 85: 2993-3001. [CrossRef] 7. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol 2008; 52: 1152-9. [CrossRef] 8. Rodondi N, den Elzen WP Bauer DC, Cappola AR, Razvi S, Walsh JP et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365-74. [CrossRef] 9. Collet TH, Gussekloo J, Bauer DC, den Elzen WP Cappola AR, Balmer P et al; Thyroid Studies Collaboration. Arch Intern Med 2012; 172: 799-809. [CrossRef] 10. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012; 379: 1142-54. [CrossRef] 11. Sgarbi JA, Villaca F, Garbeline B, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism on clinical and heart abnormalities. J Clin Endocrinol Metab 2003; 88: 1672-7. [CrossRef] 12. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006; 91:145-53. [CrossRef] 13. Monzani F, Caraccio N, Kozakowa M, Dardano A,Vittone F, Virdis A, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-con- trolled study. J Clin Endocrinol Metab 2004; 89: 2099-106. [